Indium In-111 Pentetreotide Kit Patent Expiration
Indium In-111 Pentetreotide Kit is used for detecting neuroendocrine tumors. It was first introduced by Curium Us Llc
Indium In-111 Pentetreotide Kit Patents
Given below is the list of patents protecting Indium In-111 Pentetreotide Kit, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Octreoscan | US6123916 | Therapeutic use of somatostatin peptides |
Sep 26, 2017
(Expired) | Curium |
| Octreoscan | US5776894 | Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors |
Jul 07, 2015
(Expired) | Curium |
| Octreoscan | US5753627 | Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis |
May 19, 2015
(Expired) | Curium |
Indium In-111 Pentetreotide Kit's Family Patents
Explore Our Curated Drug Screens
Indium In-111 Pentetreotide Kit Generic API Manufacturers
Only one generic application has been filed for Indium In-111 Pentetreotide Kit.
Given below is the list of companies who have filed for Indium In-111 Pentetreotide Kit generic, along with the locations of their manufacturing plants worldwide.
1. SUN PHARM INDS INC
Sun Pharmaceutical Industries Inc has filed for 1 generic for Indium In-111 Pentetreotide Kit. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 3mCi/ML | injectable | Prescription | INJECTION | AP | Jul 1, 2024 |